Find the right compounds for your research objectives
A novel 39-amino acid peptide targeting GLP-1, GIP, and glucagon receptors. Currently in Phase 3 clinical trials with promising research outcomes.
Stay informed with our latest peptide research guides and educational content.
A literature overview of BPC-157 gastrointestinal rodent models: what endpoints ethanol-lesion, restraint-stress, colitis, and fistula studies actually measured.
A literature overview of GLP-1 receptor agonist structure-activity relationship research: two-domain binding, fatty-acid modifications, and cryo-EM structures.
A literature review of GLP-1 half-life pharmacokinetic studies: native GLP-1 degradation, analog modification, and how researchers measure elimination rates.
Subscribe for exclusive discounts, new product alerts, and research insights delivered straight to your inbox.
